Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Text and Data Mining valid from 2018-03-01
Received: 20 May 2017
Accepted: 1 February 2018
First Online: 1 March 2018
Ethics approval and consent to participate
: All study materials have been reviewed and approved by the Ethical and Independent Review Services (E&I) Institutional Review Board (E&I study number 15128–01). No compensation was offered and informed consent was obtained from all patients who participated in the study.
: Not applicable.
: ASP and ACM have received consulting fees from Novartis Pharmaceuticals Corporation, the sponsor of this study. LH, JII, TT, SG, and MSD are employees of Analysis Group, which has received research funding from Novartis Pharmaceuticals Corporation. AR is an employee of Novartis Pharmaceuticals Corporation.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.